Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
about
Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen presenting cell gene deliveryMannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation.Bimodal Targeting Using Sulfonated, Mannosylated PEI for Combined Gene Delivery and Photodynamic Therapy.In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector.Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.Enhancing vaccine effectiveness with delivery technology.Total Biosynthesis and Diverse Applications of the Nonribosomal Peptide-Polyketide Siderophore YersiniabactinBiomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.
P2860
Q28817429-712CBA3D-49A9-4EA8-BBD6-257896493E6BQ35469783-F465FFFD-C674-4FE2-BDD0-FBFDFF7D302DQ36217298-FBCD2414-E643-44AC-B6C5-E4E486528D22Q37088578-B980FF92-61BF-4DF0-96FB-CDB340164FEEQ38685860-AA9241CF-E193-461F-96D4-B1A3B5207E81Q38765636-D395D12E-B0DC-416C-9509-A85890CDD55AQ41195248-C729EE04-6083-441F-803C-C19A9AC8E75EQ55432126-A67EB5FD-504B-42DA-B673-93178B18DD1B
P2860
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@ast
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@en
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@nl
type
label
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@ast
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@en
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@nl
prefLabel
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@ast
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@en
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@nl
P2093
P2860
P356
P1476
Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
@en
P2093
Anitha Ravikrishnan
Blaine A Pfeifer
Charles H Jones
Mahmoud Kamal Ahmadi
Ryan Reddinger
Snehal Rane
P2860
P304
12360-12365
P356
10.1073/PNAS.1411355111
P407
P577
2014-08-11T00:00:00Z